Hyperion DeFi, Inc. (NASDAQ:HYPD) Receives Average Recommendation of “Hold” from Brokerages

Shares of Hyperion DeFi, Inc. (NASDAQ:HYPD) have been given an average recommendation of “Hold” by the five analysts that are currently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, two have issued a hold rating and two have given a buy rating to the company. The average 12 month price objective among brokers that have covered the stock in the last year is $4.5833.

Several analysts have commented on HYPD shares. Zacks Research upgraded shares of Hyperion DeFi to a “hold” rating in a report on Monday. Weiss Ratings restated a “sell (d-)” rating on shares of Hyperion DeFi in a research note on Wednesday, October 8th. Cantor Fitzgerald assumed coverage on Hyperion DeFi in a research report on Tuesday, December 16th. They set an “overweight” rating and a $4.00 price target on the stock. Wall Street Zen upgraded Hyperion DeFi from a “sell” rating to a “hold” rating in a report on Saturday, November 22nd. Finally, Chardan Capital set a $7.75 target price on shares of Hyperion DeFi and gave the company a “buy” rating in a report on Wednesday, December 24th.

Insider Buying and Selling

In other Hyperion DeFi news, Director Ellen R. Strahlman acquired 11,856 shares of the business’s stock in a transaction on Monday, December 29th. The shares were acquired at an average price of $3.61 per share, for a total transaction of $42,800.16. Following the completion of the acquisition, the director owned 34,869 shares in the company, valued at $125,877.09. This trade represents a 51.52% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Happy David Walters bought 61,930 shares of the firm’s stock in a transaction on Wednesday, December 17th. The shares were acquired at an average cost of $3.02 per share, with a total value of $187,028.60. Following the purchase, the director directly owned 111,930 shares of the company’s stock, valued at approximately $338,028.60. This represents a 123.86% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders have acquired 161,254 shares of company stock valued at $511,126 over the last quarter. Corporate insiders own 10.86% of the company’s stock.

Hyperion DeFi Stock Performance

NASDAQ:HYPD opened at $3.37 on Wednesday. The company has a quick ratio of 2.25, a current ratio of 2.25 and a debt-to-equity ratio of 0.11. The firm’s fifty day simple moving average is $4.79 and its 200 day simple moving average is $7.60. The stock has a market cap of $27.54 million, a P/E ratio of -0.83 and a beta of 2.80. Hyperion DeFi has a twelve month low of $0.85 and a twelve month high of $17.99.

Hyperion DeFi (NASDAQ:HYPD) last posted its earnings results on Friday, November 14th. The company reported $0.05 EPS for the quarter. The firm had revenue of $0.36 million during the quarter. Hyperion DeFi had a negative net margin of 62,238.41% and a negative return on equity of 119.59%. As a group, research analysts predict that Hyperion DeFi will post -41.6 EPS for the current year.

About Hyperion DeFi

Eyenovia, Inc, an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis.